NEW YORK, Aug. 21, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate AmpliPhi Biosciences Corporation (OTCQB: APHBD), a global leader in the development of novel bacteriophage-based antibacterial therapeutics, on its listing today on the NYSE MKT. AmpliPhi previously traded on the OTCQB® Venture Market operated by OTC Markets Group.
In the past 11 months on OTCQB, AmpliPhi's 30-day average daily dollar volume has increased more than 280%," said Jason Paltrowitz, Executive Vice President - Corporate Services of OTC Markets Group. "We commend AmpliPhi on its graduation to the NYSE MKT and are proud to have contributed to its achievement of this important milestone."
AmpliPhi joins 41 other graduates to a U.S. stock exchange this year. Other 2015 graduates include: Concordia Healthcare Corporation, Cynapsus Therapeutics Inc., Real Industry, Inc. and Xcel Brands, Inc.
OTC Markets Group is the global leader in exchange graduates, advancing more than 400 companies to the New York Stock Exchange, NASDAQ and NYSE MKT in the past four years.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial markets for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into markets to inform investors of opportunities and risks: the OTCQX® Best Market; the OTCQB® Venture Market; and the OTC Pink® Open Market. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial markets, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, email@example.com
SOURCE OTC Markets Group Inc.